Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKinsey
Medtronic
Colorcon
Harvard Business School

Last Updated: February 4, 2023

Bayer Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for BAYER PHARMS, and what generic and branded alternatives to BAYER PHARMS drugs are available?

BAYER PHARMS has twenty-nine approved drugs.



Summary for Bayer Pharms
US Patents:0
Tradenames:22
Ingredients:21
NDAs:29

Drugs and US Patents for Bayer Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms NEO-CORT-DOME hydrocortisone; neomycin sulfate CREAM;TOPICAL 050237-005 Jun 5, 1984 DISCN No No See Plans and Pricing See Plans and Pricing
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985 DISCN No No See Plans and Pricing See Plans and Pricing
Bayer Pharms AZLIN azlocillin sodium INJECTABLE;INJECTION 062417-003 Oct 12, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Bayer Pharms CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019858-001 Dec 26, 1990 DISCN No No See Plans and Pricing See Plans and Pricing
Bayer Pharms CORT-DOME hydrocortisone CREAM;TOPICAL 009585-003 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Bayer Pharms AZLIN azlocillin sodium INJECTABLE;INJECTION 050562-001 Sep 3, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Bayer Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-006 Jul 24, 2000 5,177,080 See Plans and Pricing
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 5,006,530 See Plans and Pricing
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 3,799,934 See Plans and Pricing
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-005 May 24, 1999 5,177,080 See Plans and Pricing
Bayer Pharms ADALAT nifedipine CAPSULE;ORAL 019478-001 Nov 27, 1985 3,644,627 See Plans and Pricing
Bayer Pharms CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019858-001 Dec 26, 1990 4,705,789*PED See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Baxter
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.